Research · Sep 3, 2026
[MMM] 3M Thesis 2026: Brown Operational Reset Tests Post-Solventum Pure-Play
3M Company FY2025 revenue ~$24-25B (+0-2%) with adj. EPS ~$7.20-7.50 reflecting continued post-spin-off operational stabilization + Brown CEO operational reset + selected litigation cost continuation + selected industrial cycle stabilization. Diversified industrial conglomerate post-Solventum spin-off April 2024. Founded 1902 as Minnesota Mining and Manufacturing Company in Two Harbors Minnesota. 3 segments post-Solventum: Safety & Industrial ~$11B (~45% — adhesives + tapes + abrasives + personal safety including Scotch + selected) + Transportation & Electronics ~$8B (~33% — automotive films + electronics display films + aerospace + selected) + Consumer ~$5B (~20% — Post-it Notes + Scotch Tape + Scotch-Brite + selected branded products). CEO William Brown since May 1, 2024 (succeeded Mike Roman CEO 2018-2024 who became Executive Chair; Brown ex-L3Harris Technologies CEO 2018-2024 led L3Harris merger 2019 forming L3Harris ~$20B revenue defense electronics + IT services; ~30+ year military electronics + aerospace executive career). Solventum spin-off April 1, 2024 (separated $8B+ revenue Health Care division as standalone Solventum NYSE: SOLV; tax-free distribution to 3M shareholders ~1 SOLV per 4 MMM shares; transformational portfolio simplification). Major litigation: PFAS Public Water System Settlement $12.5B June 2023 (selected drinking water claims; payments through ~2036) + Combat Arms Earplugs $6B settlement August 2023 (selected payments) + continuing PFAS litigation (selected commercial customer + state government); cumulative ~$10B+ exposure; selected $1-2B annual litigation cash payments through ~2030. Dividend reduced $6.04 → $2.80 in 2024 (post-Solventum + post-litigation reset; ended 65-year dividend aristocrat status — selected painful cut justified by reduced post-spin cash flow + litigation cash needs). Capital return: dividend $2.80/share + buybacks $1B; net debt $10-12B; A2/A investment grade. FY2026 thesis: Brown reset + post-Solventum + PFAS resolution + capital return rebuilding. Risks: PFAS litigation continuing, industrial cycle, Brown turnaround execution.